En Es
Categories

QIAGEN

Qiagen is a provider of sample and assay technologies for molecular diagnostics and applied testing, including complete kits for pre-defined applications in sample preparation and analysis, and individual enzymes and reagents. It also offers instruments for automating the full range of laboratory procedures, from the initia ...
Products Covid-19NewsSummary
Close

Covid-19 QIAGEN

Clinical Laboratory

Viral RNA UM Kit
QIAprep& Viral RNA UM Kit

The QIAprep& Viral RNA UM Kit combines a liquid-based sample preparation step completed in only two minutes with real-time RT-PCR detection in a streamlined workflow. Users can automate this method with standard lab equipment for any throughput, assay and reaction need from single to multiplex testing. The kit is compatible with dual-labeled probes, e.g., TaqMan probes in multiplex one-step RT-PCR detection of one or more targets (altogether, up to 4 assays including the internal controls).
More details

SARS-CoV-2 Primer Panel
QIAseq SARS-CoV-2 Primer Panel

The QIAseq SARS-CoV-2 Primer Panel combines both reverse transcription and whole genome enrichment of the viral RNA for targeting SARS-CoV-2 to generate amplicons for downstream library creation. When paired with a QIAseq FX DNA Library UDI Kit, sequencing-ready libraries compatible with Illumina platforms can be constructed. QIAseq SARS-CoV-2 primer pools utilize designs from the ARTIC V3 primers which have also gone through an in silico check to reduce chances for dimerization during sample enrichment.
More details

SARS-CoV-2 Antigen Testing Device
QIAreach eHub

The QIAreach eHub portable SARS-CoV-2 antigen testing device, in combination with QIAreach assay eSticks, provides a simplified workflow for multiple in vitro diagnostic tests, using state-of-the-art nanoparticle fluorescence detection technology. QIAreach assay eSticks are single-use tests that include a lateral flow strip and optoelectronics that perform test measurements and interpret results. The QIAreach eHub provides power to the QIAreach test eStick to run the test when the test eStick is connected to any one of the eHub eStick ports. The QIAreach eHub visually communicates test progress and results to the user via a display screen specific to each eHub port.
More details

SARS-CoV-2 RUO Solution
QuantiFERON SARS-CoV-2 RUO

The QuantiFERON SARS-CoV-2 RUO solution is an original combination of blood collection tubes containing innovative specific peptides formulated to stimulate lymphocytes in heparinized whole blood involved in cell-mediated immunity. Plasma from the stimulated samples can then be used for detection of IFN-γ using a simple ELISA. The QuantiFERON SARS-CoV-2 RUO solution is composed of several components that can be ordered separately or combined to provide better research insights on patients’ immune status.
More details

Flu A/SARS-CoV-2 Test
NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test

The NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test is a multiplex polymerase chain reaction (PCR) test that detects and differentiates influenzas A and B, respiratory syncytial virus (RSV) and SARS-CoV-2 infections within 80 minutes. The respiratory test takes advantage of the NeuMoDx 96 and NeuMoDx 288 molecular systems’ automated three-step workflow and has obtained CE-IVD approval for the use of saliva samples collected with the NeuMoDx Saliva Collection Kit, which includes a collection vial, stabilization tube and pipette.
More details

SARS-CoV-2 Assay
NeuMoDx SARS-CoV-2 Assay

The NeuMoDx SARS-CoV-2 Assay is a real-time RT-PCR diagnostic test intended for the qualitative detection of SARS-CoV-2 coronavirus RNA in nasal, nasopharyngeal and oropharyngeal swabs in transport medium, and bronchoalveolar lavage (BAL) specimens from individuals suspected of COVID-19 by their healthcare provider. This test is performed on the NeuMoDx 288 and NeuMoDx 96 Molecular Systems and is also for use with saliva specimens that are collected within a healthcare setting by individuals using the NeuMoDx Saliva Collection Kit when determined to be appropriate by a healthcare provider.
More details

Molecular System
NeuMoDx 96

The NeuMoDx 96 Molecular System is designed for the automated extraction and isolation of nucleic acids, as well as the automated amplification and detection of target nucleic acid sequences by fluorescence-based PCR. Consisting of the instrument with touchscreen computer, accessories, and reagents and consumables, the system is intended for in vitro diagnostic (IVD) use in performing NeuMoDx-validated nucleic acid testing in clinical laboratories.
More details

Molecular System
NeuMoDx 288

The NeuMoDx 288 Molecular System is designed for the automated extraction and isolation of nucleic acids, as well as the automated amplification and detection of target nucleic acid sequences by fluorescence-based PCR. Consisting of the instrument with touchscreen computer, accessories, and reagents and consumables, the instrument is intended for in vitro diagnostic (IVD) use in performing NeuMoDx-validated nucleic acid testing in clinical laboratories.
More details

SARS-CoV-2 Antigen Test
QIAreach SARS-CoV-2 Antigen Test

The QIAreach SARS-CoV-2 Antigen Test is a scalable, digital assay for the in vitro detection of the SARS-CoV-2 nucleocapsid protein antigen that allows testing up to eight patients simultaneously for SARS-CoV-2 infection with the first positive results in just two minutes. As part of the complete QIAreach solution for SARS-CoV-2 testing, the test will run simultaneously with the QIAreach Anti-SARS-CoV-2 Total Test on a single QIAreach eHub.
More details

SARS-CoV-2 Antibody Test
QIAreach Anti-SARS-CoV-2 Total Test

The QIAreach Anti-SARS-CoV-2 Total Test is a rapid, digital lateral flow serological test, using nanoparticle fluorescence, intended for qualitative detection of total antibodies to SARS-CoV-2 in human serum and plasma (heparin, EDTA). It is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.
More details

Respiratory SARS-CoV-2 Panel
QIAstat-Dx Respiratory SARS-CoV-2 Panel

The QIAstat-Dx Respiratory SARS-CoV-2 Panel is a multiplex syndromic cartridge that detects and differentiates 21 respiratory targets, including SARS-CoV-2 from nasopharyngeal swabs (NPS) eluted in universal transport media (UTM). It offers an intuitive workflow with less than one-minute hands-on time and provides comprehensive qualitative results in about an hour.
More details
Close

News of QIAGEN

Qiagen Partners with Sysmex for Development and Commercialization of Cancer Companion Diagnostics

02 Jul 2021
Qiagen Partners with Sysmex for Development and Commercialization of Cancer Companion Diagnostics
QIAGEN N.V. (Venlo, Netherlands) and Sysmex Corporation (Kobe, Japan) have entered into a global strategic alliance for the development and commercialization of cancer companion diagnostics, which will leverage both QIAGEN’s leadership in this field and Sysmex’s Plasma-Safe-SeqS technology for next generation sequencing (NGS).
Read More

QIAGEN to Focus on Molecular Testing amidst Coronavirus Pandemic after Voluntary Public Takeover Offer by Thermo Fisher Falls Short

14 Aug 2020
QIAGEN to Focus on Molecular Testing amidst Coronavirus Pandemic after Voluntary Public Takeover Offer by Thermo Fisher Falls Short
QIAGEN N.V. (Venlo, Netherlands) plans to continue executing its growth strategy aimed at creating significant value for shareholders and other stakeholders after the voluntary public takeover offer by Thermo Fisher Scientific Inc. (Waltham, MA, USA) failed to achieve the minimum 66.67% acceptance threshold from QIAGEN shareholders.
Read More

QIAGEN Enters into Agreement to Acquire STAT-Dx

13 Feb 2018
QIAGEN Enters into Agreement to Acquire STAT-Dx
QIAGEN N.V. has entered into an agreement to acquire STAT-Dx, a privately-held company which develops next generation of multiplex diagnostics for one-step, fully integrated molecular analysis of common syndromes using a novel system based on real-time PCR technology and proven QIAGEN chemistries.
Read More

Qiagen Acquires Bioinformatics Firm OmicSoft

12 Jan 2017
Qiagen Acquires Bioinformatics Firm OmicSoft
QIAGEN N.V., a provider of sample and assay technologies, has acquired OmicSoft Corporation, which focuses on biomarker data management, visualization, and analysis.
Read More
Close

About QIAGEN

Qiagen is a provider of sample and assay technologies for molecular diagnostics and applied testing, including complete kits for pre-defined applications in sample preparation and analysis, and individual enzymes and reagents. It also offers instruments for automating the full range of laboratory procedures, from the initial sample preparation to the final test result.
FaceBook Twitter Google+ Linked in
SARS-CoV-2 Antigen Testing Device

SARS-CoV-2 Antigen Testing Device

Model: QIAreach eHub
Request Information

Description:

The QIAreach eHub portable SARS-CoV-2 antigen testing device, in combination with QIAreach assay eSticks, provides a simplified workflow for multiple in vitro diagnostic tests, using state-of-the-art nanoparticle fluorescence detection technology. QIAreach assay eSticks are single-use tests that include a lateral flow strip and optoelectronics that perform test measurements and interpret results.
Read More

Full Description Specifications

Description

The QIAreach eHub portable SARS-CoV-2 antigen testing device, in combination with QIAreach assay eSticks, provides a simplified workflow for multiple in vitro diagnostic tests, using state-of-the-art nanoparticle fluorescence detection technology. QIAreach assay eSticks are single-use tests that include a lateral flow strip and optoelectronics that perform test measurements and interpret results. The QIAreach eHub provides power to the QIAreach test eStick to run the test when the test eStick is connected to any one of the eHub eStick ports. The QIAreach eHub visually communicates test progress and results to the user via a display screen specific to each eHub port. Request Information

Specifications

Dimensions and weight

• Dimensions Width: 304 x 112 x 51 mm (12 x 4.4 x 2 in)
• Weight 1000 g (2.2 lb)

Power requirements
• USB Charger Power Adapter (supplied)
• Voltage 100–240 VAC
• Power 0.4A max
• Frequency 50–60 Hz
• Line regulation ± 1%
• Load regulation ± 5%
• Line Frequency Variation ± 3 Hz

QIAreach eHub device:
• Voltage 5V DC
• Power 1.0A
• Internal Li-Ion battery (non user-seviceable):
 Voltage: 3.7V nominal
 Capacity: 3350 mAh nominal

Operating conditions
• Air Temperature 15–30°C (59–86°F)
• Relative Humidity 30–65% (non-condensing)
• Place of Operation For Indoor use only

Transport conditions
• Air Temperature 5–50°C (41–122°F)
• Relative Humidity Maximum 70% relative humidity, non-condensing

Storage conditions
• Air Temperature 15–30°C (59–86°F)
• Relative Humidity 30–65% (non-condensing) Request Information

Send A Message To This Supplier

* Required Information
* Email
To
QIAGEN (SARS-CoV-2 Antigen Testing Device)
* Message

Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions